We would love to hear your thoughts about our site and services, please take our survey here.
"10000 shares Dubs @ £3.05 sold @ £3.27 mate"
Sweet I love those cash in days.
Bought few dips at 2.96 few weeks back and could not resist keeping them when we went well above 3.50. Looney is possibly the best we could hope for young enough to bring good innovative DNA and wise enough to keep the balance sheet on track.
Polluting Investor thank God Looney it's doing an awesome job at re shaping the company future.
Your views were probably ok 100 years ago.
"When I raised the concern almost two months ago on the Novacyt BB , someone punched me through the laptop screen. LOL"
.About cold storage that is.
Parks an apology would also be nice.
When I raised the concern almost two months ago on the Novacyt BB , someone punched me through the laptop screen. LOL
Kaeren
Posted in: NCYT
Posts: 195
Price: 222.50
No Opinion
RE: Ambient12 Jun 2020 15:44
Just slapped Theoriginalnova's link on the GDR board, I hold. K
....That's how the ruins of a Novacyt investor looks like....
Thanks for the recap Magsy
I just don't understand. How many -£ shares we still got floating. The only way to end this is floading the market with GDR tests.
Could be Spreadex a partial cause for the drag?
David the Messiah
Showcase the product. If the test does what it says on the specs we should not worry about sales.
The selling has been going on for a while now I was expecting few more days of drag but not this kind of pressure. Cash was raised to support the sales,just wondering now what's the approach to "Go to market".
I am literally sitting holding a bag of ice on my forehead.
Puzzled by Novacyt holding the fort and wondering what the ##&£- went wrong.
Same here Teab
I would narrow down to point 1,5,6
A shame really.
Stop moaning about RNS.
Why is Novacyt not down as well? I need to understand.
Drop cannot be linked to the general sentiment about Covid19.
Not sure everyone got it. The design freeze that everyone is awayting is probably the one that Abingdon decided to use for production.
Beauty is in the eyes of the beholder.
Gents,
It's not productive to single out few sentences and paint a nice fairy tale around them.
Check the timeline, give it a context and draw your own conclusions
Omega is going to commit to Mologic pipeline is it that difficult to see?
@Al
Difficult to value all orher products on the pipeline without considering the Covid19 reshuffle. The diagnostic field has gained a new status and that must be factored in.
GDR catalogue represent the best risk rewards Covid19 position for me and Avacta a good long term position to build on Affimers technology ( not invested).
Punit you are intentionally funny.
In2 Win
You nailed. That's everyone worry. As we go into late June what will be the media pressure regarding Covid19? Will a good RNS have the same impact that it had a month ago?
Will the the Oxford vaccine trial affect the outlook of the last quarter. How are competitors faring? You outweigh your risk Vs rewards and make your move